Marché mondial des technologies d’inhalateurs intelligents – Tendances et prévisions de l’industrie jusqu’en 2029

Analyse et taille du marché

L'industrie des technologies d'inhalateurs intelligents a connu un développement optimal ces dernières années et devrait le rester dans les années à venir. La croissance de la taille de l'industrie des technologies d'inhalateurs intelligents peut être attribuée à l'augmentation des investissements dans les activités de recherche et développement, à l'entrée de nouveaux acteurs, à la nouveauté des produits, aux avancées technologiques, à l'allocation réelle des ressources et à la concurrence croissante entre les concurrents commerciaux pour élargir leur base locale et leur clientèle.

Français Data Bridge Market Research analyse que le marché de la technologie des inhalateurs intelligents, qui était de 57,61 milliards USD en 2021, devrait atteindre 196,29 milliards USD d'ici 2029 et devrait connaître un TCAC de 16,56 % au cours de la période de prévision de 2022 à 2029. Le rapport de marché organisé par l'équipe de recherche sur le marché de Data Bridge comprend une analyse approfondie des experts, une épidémiologie des patients, une analyse du pipeline, une analyse des prix et un cadre réglementaire.

Définition du marché

Les inhalateurs intelligents sont des appareils destinés à se connecter à l'application mobile via Bluetooth pour gérer correctement les troubles respiratoires chroniques et améliorer le mode de vie du patient. La forte demande d'inhalateurs intelligents s'est amplifiée de manière exponentielle en raison de la prévalence croissante des maladies respiratoires telles que l'asthme, la fibrose kystique, les maladies pulmonaires obstructives chroniques, entre autres. Les inhalateurs intelligents sont une mise à niveau par rapport aux inhalateurs conventionnels. Ils incluent l'utilisation de la technologie de liaison et l'utilisation de capteurs grâce auxquels le système général collecte et stocke des informations concernant les habitudes et les besoins du patient. Cette technologie de connectivité permet d'informer les patients de la nécessité de réapprovisionner les inhalateurs et du moment où prendre le médicament, en augmentant même la quantité en fonction de l'état du patient.

Portée du rapport et segmentation du marché

Smart Inhaler Technology Market Dynamics

Drivers

• Increasing worldwide demand for digital healthcare solutions

 Since changing traditional medical protocols and increasing penetration of IoT in the healthcare and medical devices sector. Moreover, the increasing geriatric population coupled with the surge in respiratory disease incidences is driving the growth of smart inhalers crosswise the world.

• Worldwide demand for smart inhalers is increasing

On account of growing air pollution at an upsetting rate and the pulmonary disorders caused due to it. For instance, Air pollution kills an estimated 7 million people worldwide every year from acquaintance to fine particles in polluted air that main to diseases such as stroke, heart disease, lung cancer, chronic obstructive pulmonary diseases, and respiratory infections, including pneumonia.

Rise in the levels of pollution worldwide which has resulted in the increase of populace susceptible to chronic obstructive pulmonary diseases acts as the vital factor escalating the market growth, also rising prevalence Of COPD and asthma, increase in population vulnerable to indoor air pollutants, increase in air pollution, rising alliance between pharma and digital health companies and rising occurrence of respiratory diseases are the major factors among others driving the smart inhalers market.

Opportunities

Growth of the smart inhaler technology market is the advancement in medical technology, the need to control the surging treatment cost linked with respiratory disorders. After drugs to surgeries, to other medical procedures, nothing costs less than a few lakhs. Smart inhalers are measured a promising novelty that monitors medication adherence based on the type of respiratory disease. Thus, refining the patient’s outcome and reducing the treatment costs. 

Restraints/Challenges
Though, some of the restraints in the market include a lack of awareness and the overall high cost of inhalers. In addition to this, the apprehensions related to misusing data and data privacy are obstructing the growth of this market all over the world. However, misusing data and data privacy and general high cost of asthma and COPD treatment are the main factors among others which will obstruct the market growth, and will further challenge the growth of smart inhaler technology market in the forecast period 2022-2029. However, certain factors such as the high cost of the smart inhalers and the availability of additional manual inhalers may pose a slight hurdle for developing the smart inhaler technology market.

This smart inhaler technology market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the smart Inhaler Technology market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Smart Inhaler Technology Market

The COVID-19 outbreak has caused disorder on worldwide financial and social systems. The disease has entered several industries' value and supply chains, including the smart inhaler technology market. The government imposed lockdowns in several locations. We will study the impact of the COVID-19 pandemic on the global market, looking at both demand and supply. The COVID-19 pandemic's short- and long-term impacts would be explored to deliver a summary. This would help build business plans for all market participants, including manufacturers, vendors, traders, distributors, and end-users, during and after the epidemic.

Recent Development

• In 2019, Lupin publicized launching “ADHERO,” which is a connected smart device for metered dose inhalers and promises to ensure better adherence to breath therapy for COPD treatment.
• In August 2020, Propeller Health cooperated with Novartis to connect the Propeller digital health platform to Enerzair® and Atectura® Breezhaler to treat uncontrolled asthma and started the distribution of the product in Japan.
• In June 2020, Aptar Pharma united with Lupin Limited to launch India’s first connected device for metered-dose nebulizers (MDI) called ADHERO.

Global Smart Inhaler Technology Market Scope

The smart inhaler technology market is segmented on the basis of type, price range, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Products

• Inhalers

Dry Powder Inhalers

Metered Dose Inhalers

• Nebulizers

On the basis of products the smart inhalers market is divided into inhalers and nebulizers.

The inhalers are further divided into dry powder inhalers and metered dose inhalers.

Indication

• Asthma
• COPD

On the basis of indication the smart inhalers market is segmented into asthma and COPD.

Distribution channels

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

On the basis of distribution channels, the smart inhalers market is divided into hospital pharmacies, retail pharmacies and online pharmacies.

 Smart Inhaler Technology Market Regional Analysis/Insights

The smart Inhaler technology market is analysed and market size insights and trends are provided by country, type, price range, application and end user as referenced above.

The countries covered in the smart Inhaler technology market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the smart inhalers market due to growing per capita income, rising prevalence Of COPD and asthma, growth in population susceptible to indoor air pollutants, increase in air pollution, rising collaboration between pharma and digital health companies and rising prevalence of respiratory diseases in this region.

 Asia-Pacific is the expected region in terms of development in smart inhalers market due to rising need to rising healthcare expenditure and an cumulative number of product growth in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Croissance des infrastructures de santé Base installée et pénétration des nouvelles technologies

Le marché de la technologie des inhalateurs intelligents vous fournit également une analyse détaillée du marché pour chaque pays, la croissance des dépenses de santé pour les équipements en capital, la base installée de différents types de produits pour le marché de la technologie des inhalateurs intelligents, l'impact de la technologie à l'aide de courbes de vie et les changements dans les scénarios réglementaires des soins de santé et leur impact sur le marché de la technologie des inhalateurs intelligents. Les données sont disponibles pour la période historique 2010-2020.

Analyse du paysage concurrentiel et des parts de marché de la technologie des inhalateurs intelligents

Le paysage concurrentiel du marché de la technologie des inhalateurs intelligents fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché de la technologie des inhalateurs intelligents.

Certains des principaux acteurs opérant sur le marché de la technologie des inhalateurs intelligents sont :

• Adherium (États-Unis)
• AstraZeneca (Royaume-Uni)
• Boehringer Ingelheim International GmbH (Allemagne)
• Cohero Health, Inc. (États-Unis)
• Groupe de sociétés GSK (Royaume-Uni)
• Teva Pharmaceutical Industries Limited (Israël)
• Vectura Group Ltd. (Royaume-Uni) Propeller Health (États-Unis)
• Novartis SA (Suisse)
• OPKO Health Inc. (États-Unis)
• AptarGroup, Inc. (États-Unis)
• Sensirion AG (Suisse)

SKU-68477